We extend our sincere thanks to our customers, partners, and hospital pharmacy teams for their trust, partnership, and support over the years. It has been our privilege to help meet your patient care needs through our 503B compounding operations.

While our 503B compounding business has permanently ceased operations, Hikma remains committed to supporting hospitals, health systems, and clinics through our broad portfolio of sterile injectable medications.

For product information, resources, and support, please visit Hikma.com to learn more about Hikma’s sterile injectables portfolio.